Skip to main content
. Author manuscript; available in PMC: 2021 Mar 13.
Published in final edited form as: ACS Infect Dis. 2020 Jan 24;6(3):393–405. doi: 10.1021/acsinfecdis.9b00354

Table 2.

Inhibition of DNTB and GSSG reducing activities of TGR

Compound IC50 (DTNB) (μM) IC50 (GSSG) (μM)
1 0.33 ± 0.07 0.39 ± 0.07
2 0.21 ± 0.02 0.23 ± 0.03
3 2.84 ± 0.08 2.49 ± 0.11
4 2.01 ± 0.14 2.20 ± 0.20
5 0.06 ± 0.01 0.05 ± 0.01
6 0.14 ± 0.01 0.15 ± 0.02
7 0.09 ± 0.02 0.13 ± 0.03
8 0.13 ± 0.04 0.33 ± 0.05